AI Model Has Promise for Predicting Checkpoint Inhibitor Activity in NSCLC

(MedPage Today) -- Artificial intelligence (AI)-aided analysis of pathology slides showed potential as a predictive biomarker for non-small cell lung cancer (NSCLC) response to immune checkpoint inhibitors (ICIs), a multicenter study showed.
The...